fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

EU Countries Donate 2M Doses Of J&J COVID Vaccine To Nigeria As A Part Of COVAX Initiative

By John F. Heerdink, Jr.

Reportedly, Nigeria has received 2 million doses of the Johnson & Johnson (JNJ) COVID-19 vaccine from Finland, Greece, and Slovenia. More EU donations are expected to arrive in the coming weeks, as part of a donation pledge by the European Union to African countries via the COVAX initiative launched by the World Health Organization (WHO) in 2020 to distribute vaccines to some of the world’s poorest people.

“This batch of vaccines will expire in August 2023. So we have that ample time to administer before that time,” stated Faisal Shuaib, executive director of Nigeria’s National Primary Health Care Development Agency (NPHCDA).

Samuela Isopi, the EU ambassador to Nigeria, said the doses were “part of a global donation of almost 20 million J&J doses from EU member states to Nigeria” and more would arrive in the coming weeks. The vaccines are currently placed in a cold room at the airport of the Nigerian capital Abuja.

The country had been accepting vaccines with short shelf lives from donor nations in an attempt to use them quickly and provide basic protection for Nigerians due to vaccine scarcity in the past. In December. the government informed it had destroyed about 1 million donated vaccine doses after they had expired.


Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare-focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.

If you liked this story please consider, visiting the Atossa Therapeutics (ATOS) dedicated page at Vista Partners to learn about the Seattle-based biotech firm’s work towards finding therapeutic treatments for Breast Cancer and the Coronavirus. 


Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.

Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.

(Read Original Story: UPDATE 2-Nigeria receives 2 million doses of J&J COVID vaccine from EU countries in Reuters)


YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

Connect with us